Austrália - inglês - Department of Health (Therapeutic Goods Administration)

rn labs pty ltd - riboflavin sodium phosphate, quantity: 25 mg (equivalent: riboflavin, qty 20 mg); calcium folinate, quantity: 540 microgram (equivalent: folinic acid, qty 500 microgram); hydroxocobalamin, quantity: 500 microgram; calcium pantothenate, quantity: 218 mg (equivalent: pantothenic acid, qty 200 mg); pyridoxal 5-phosphate, quantity: 29.2 mg (equivalent: pyridoxine, qty 20 mg); nicotinamide, quantity: 150 mg; biotin, quantity: 500 microgram; inositol, quantity: 100 mg; thiamine hydrochloride, quantity: 56 mg (equ - capsule, hard - excipient ingredients: leucine; colloidal anhydrous silica; hypromellose - enhance/promote energy levels ; helps enhance/promote general health and wellbeing ; helps enhance/promote red blood cell health ; maintain/support healthy cardiovascular system function ; maintain/support healthy immune system function ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; maintain/support (state vitamin/mineral) within normal range ; support healthy stress response in the body ; aid/assist/helps synthesis of neurotransmitters ; decrease/reduce/relieve symptoms of premenstrual tension

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

rn labs pty ltd - biotin, quantity: 500 microgram; hydroxocobalamin, quantity: 500 microgram; inositol, quantity: 100 mg; riboflavin sodium phosphate, quantity: 26.3 mg (equivalent: riboflavin, qty 20 mg); calcium folinate, quantity: 542 microgram (equivalent: folinic acid, qty 500 microgram); nicotinamide, quantity: 150 mg; thiamine hydrochloride, quantity: 63.5 mg (equivalent: thiamine, qty 50 mg); calcium pantothenate, quantity: 218.3 mg (equivalent: pantothenic acid, qty 200 mg); pyridoxal 5-phosphate monohydrate, quantity: 31.3 mg (equivalent: pyridoxine, qty 20 mg) - capsule, hard - excipient ingredients: colloidal anhydrous silica; hypromellose; leucine; microcrystalline cellulose - enhance/promote energy levels ; helps enhance/promote general health and wellbeing ; helps enhance/promote red blood cell health ; maintain/support healthy cardiovascular system function ; maintain/support healthy immune system function ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; maintain/support (state vitamin/mineral) within normal range ; support healthy stress response in the body ; aid/assist/helps synthesis of neurotransmitters ; decrease/reduce/relieve symptoms of premenstrual tension

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

w l gore & associates (australia) pty ltd - 47932 - multiple peripheral arteries stent - a self expanding endoluminal endoprosthesis with an eptfe lining and external nitinol support. its surface is modified with covalently bound bioactive heparin. it is provided compressed and attached to a dual lumen delivery catheter. the larger central catheter lumen is used for flushing and guidewire introduction. the smaller lumen contains elements of the deployment mechanism. 2 radiopaque bands are attached to the catheter shaft, marking the ends of the compressed endoprosthesis the gore viabahn endoprosthesis with propaten bioactive surface is a flexible, self-expanding endoluminal prosthesis for endovascular grafting of peripheral arteries.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

rti surgical australia pty ltd - 47967 - bone matrix implant, composite - nanoss bioactive is a resorbable porous calcium phosphate bone void filler for use as a bone graft substitute or bone void filler. it is an osteoconductive implant with a multidimensional porosity similar to human cancellous bone and acts as a scaffold for the in-growth of new bone. the product forms a cohesive and adhesive dough with a putty-like consistency upon rehydration, allowing the shape of the implant to conform to the defect maximizing direct contact with viable host bone. nanoss bioactive is intended for bony voids or gaps that are not intrinsic to the stability of bony structure. the product is indicated to be gently packed into bony voids or gaps in the spine in conjunction with bone marrow aspirate or bone marrow aspirate and autograft bone. these defects may be surgically created osseous defects or defects created from traumatic injury to the bone. the product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia - 47971 - dental bone matrix implant, synthetic - this is an osteoconductive bioactive device used for alloplastic bone grafting of osseous defects. it is a pre-mixed composite of bioactive calcium-phospho-silicate particulate and a synthetic, absorbable binder. the bioactive particulate is composed solely of elements that exist naturally in normal bone (ca, p, na, si, o). the absorbable binder is a combination of polyethylene glycol and glycerin. the device requires no mixing or preparation prior to application. this device is in the form of a putty that is intended to be used to provide, biocompatible synthetic bone graft material for use in oral, dental intraosseous, and craniofacial defects. it is used alone in a manner comparable to autogenous bone graft chips or allograft bone particulate(demineralized freeze dried bone) or may be mixed with either as a bone graft extender. typical uses include: periodontal/infrabony defects; ridge augmentation(sinusotomy, osteotomy, cystectomy); extraction sites (ridge maintenance/augmentation, implant preperation/placement); sinus lifts; cystic cavities; cranio-facial augmentation. for large defects, a mixture of putty with equal volume of allograft or autograft bone and bone marrow may improve new bone formation.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 36379 - circulatory assist unit, pump, centrifugal - the affinity cp centrifugal blood pump with carmeda bioactive surface is coated with a nonleaching bioactive surface (heparin) to enhance blood compatibility and provide thromboresistant blood-contacting surfaces. the device is designed to move blood by centrifugal force generated by a combination of a smooth rotating cone and low-profile impeller fins. energy is transferred from the pump in the form of pressure and velocity as the blood is driven toward the outlet port of the pump. the affinity cp centrifugal blood pump with carmeda bioactive surface is used to pump blood through the extracorporeal bypass circuit for extracorporeal circulatory support for periods appropriate to cardiopulmonary bypass (up to 6 hours). it is also indicated for use in extracorporeal support systems (for periods up to 6 hours) not requiring complete cardiopulmonary bypass (eg, valvuloplasty, circulatory support during mitral valve reoperation, surgery of the vena cava or aorta, liver transplants).

Cingapura - inglês - HSA (Health Sciences Authority)

novomed incorporation pte. ltd. - general & plastic surgery - the gore® viabahn® endoprosthesis with heparin bioactive surface is indicated for improving blood flow in patients with symptomatic peripheral arterial disease in superficial femoral artery lesions up to 270 mm in length with reference vessel diameters ranging from 4.0 – 7.5 mm. the gore® viabahn® endoprosthesis with heparin bioactive surface is indicated for improving blood flow in patients with symptomatic peripheral arterial disease in iliac artery lesions up to 80 mm in length with reference vessel diameters ranging from 4.0 – 12 mm.

Cingapura - inglês - HSA (Health Sciences Authority)

medtronic international, ltd. - general hospital - it is intended for aspirating air from the aorta during cardiopulmonary bypass surgery. the device comes coated or uncoated with carmeda® bioactive surface.

Cingapura - inglês - HSA (Health Sciences Authority)

stryker singapore private limited - orthopaedics - vitoss bioactive foam bone graft substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. vitoss bioactive foam is indicated for use in the treatment of surgically created osseous defects or osseous defects created from traumatic injury to the bone. vitoss bioactive foam bone graft substitute is intended to be used for filling bony voids or gaps of the skeletal system (i.e., the extremities, pelvis, and spine, which includes posterolateral fusion procedures) and may be combined with saline, autogenous blood, and/or bone marrow. following placement in the bony void or gap, the scaffold resorbs and is replaced with bone during the healing process.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

new image international pty ltd - colostrum powder - bovine -